Abstract
Most human sequence variation is in the form of single-nucleotide polymorphisms1,2,3 (SNPs). It has been proposed that coding-region SNPs (cSNPs) be used for direct association studies to determine the genetic basis of complex traits4,5. The success of such studies depends on the frequency of disease-associated alleles, and their distribution in different ethnic populations6,7. If disease-associated alleles are frequent in most populations, then direct genotyping of candidate variants could show robust associations in manageable study samples6. This approach is less feasible if the genetic risk from a given candidate gene is due to many infrequent alleles. Previous studies of several genes demonstrated that most variants are relatively infrequent2,3 (<0.05). These surveys genotyped small samples (n<75) and thus had limited ability to identify rare alleles. Here we evaluate the prevalence and distribution of such rare alleles by genotyping an ethnically diverse reference sample that is more than six times larger than those used in previous studies8 (n=450). We screened for variants in the complete coding sequence and intron-exon junctions of two candidate genes for neuropsychiatric phenotypes: SLC6A4, encoding the serotonin transporter; and SLC18A2, encoding the vesicular monoamine transporter9,10. Both genes have unique roles in neuronal transmission, and variants in either gene might be associated with neurobehavioral phenotypes11,12,13.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nickerson, D.A. et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nature Genet. 19, 233–240 (1998).
Cargill, M. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22, 231–238 (1999).
Halushka, M.K. et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature Genet. 22, 239–247 (1999).
Collins, F.S., Guyer, M.S. & Chakravarti, A. Variations on a theme: cataloging human DNA sequence variation. Science 278, 1580–1581 (1997).
Lander, E.S. The new genomics: global views of biology. Science 274, 536–539 (1996).
Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516–1517 (1996).
Risch, N. Searching for genetic determinants in the new millennium. Nature 405, 847–856 (2000).
Collins, F.S., Brooks, L.D. & Chakravarti, A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 8, 1229–1231 (1998).
Liu, Y. et al. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70, 539–551 (1992).
Blakely, R.D., De Felice, L.J. & Hartzell, H.C. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol . 196, 263–281 (1994).
Liu, Y. et al. Molecular analysis of neurotransmitter transport into secretory vesicles. Cold Spring Harb. Symp. Quant. Biol. 61, 747–758 (1996).
Peter, D. et al. Drug interactions with vesicular amine transport. NIDA Res. Monogr. 161, 176–200 (1996).
Lesch, K.P & Mössner, R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol. Psych. 44, 179–192 (1998).
Hamblin, M.T. et al. Detection of the signature of natural selection in humans: evidence from the duffy blood group locus. Am. J. Hum. Genet. 66, 1669–1679 (2000).
Tajima, F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123, 585–595 (1989).
Hayward, C. & Brock, D.J.H. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies. Hum. Mutat. 10, 415–423 (1997).
Rees, J.L. et al. Genetic studies of the human melanocortin-1 receptor. Ann. NY Acad. Sci. 885, 134–142 (1999).
Xu, W. et al. Structural organization of the human vesicular monoamine transporter type-2 gene and promoter analysis using the jellyfish green fluorescent protein as a reporter. Mol. Brain Res. 45, 41–49 (1997).
Jones, A.C. et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin. Chem. 45, 1133–1140 (1999).
Acknowledgements
We thank E. Lander and D. Altshuler for SLC6A4 primer sequences, and M. Slatkin, I. Herskowitz and L.A. McInnes for helpful discussions. This work was supported by grants MH01375, MH49499 and GM61390 from the National Institutes of Health. C.E.G. was supported by a grant from the Klingenstein Third Generation Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Glatt, C., DeYoung, J., Delgado, S. et al. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet 27, 435–438 (2001). https://doi.org/10.1038/86948
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/86948
This article is cited by
-
Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India
Tumor Biology (2014)
-
A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders
Molecular Autism (2013)
-
Vesicular Integrity in Parkinson’s Disease
Current Neurology and Neuroscience Reports (2013)
-
Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action
Psychopharmacology (2012)
-
Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study
Molecular Psychiatry (2011)